Single dose PK study on Patients [Design Issues]

posted by Ohlbe – France, 2024-05-15 11:39 (397 d 11:35 ago) – Posting: # 23997
Views: 3,992

Dear Pharma_88,

You are referring to a general FDA guidance, which gives general recommendations. Did they publish a product-specific guidance for your product ? It would overrule the general guidance.

The type of study to be performed depends on how the drug is normally used according to its labelling. For instance:

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
14 visitors (0 registered, 14 guests [including 10 identified bots]).
Forum time: 23:14 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5